Clinician Scientist - Anthony Kong
Improving our understanding of response and resistance to targeted therapies
Project Summary
The lab is interested in HER (ErbB) family members and their inhibitors in relation to breast cancer treatment. We use a multidisciplinary approach, including FRET, conventional biochemistry methods and immunohistochemistry in our research. We conduct translational research based on two-way approach: to bring clinical questions to bench research and translate bench findings to clinical trials.
